tiprankstipranks
Advertisement
Advertisement

INBX Stock Latest News

Inhibrx price target raised to $325 from $300 at Stifel
The FlyInhibrx price target raised to $325 from $300 at Stifel
3d ago
INBX
Inhibrx reports Q1 EPS ($2.15) vs. ($2.80) last year
PremiumThe Fly
Inhibrx reports Q1 EPS ($2.15) vs. ($2.80) last year
4d ago
INBX
Inhibrx Biosciences Reports Positive Interim Phase 2 Results
PremiumCompany Announcements
Inhibrx Biosciences Reports Positive Interim Phase 2 Results
7d ago
8K
INBX
Inhibrx’s INBRX-106 shows potential benefit in HNSCC
PremiumThe Fly
Inhibrx’s INBRX-106 shows potential benefit in HNSCC
7d ago
INBX
Inhibrx initiated with an Outperform at LifeSci Capital
PremiumThe Fly
Inhibrx initiated with an Outperform at LifeSci Capital
24d ago
INBX
Inhibrx price target raised to $300 from $150 at Stifel
PremiumThe FlyInhibrx price target raised to $300 from $150 at Stifel
26d ago
INBX
Midday Fly By: Boeing, AT&T report Q1 beats
Premium
The Fly
Midday Fly By: Boeing, AT&T report Q1 beats
26d ago
T
BA
Inhibrx trading halted, volatility trading pause
Premium
The Fly
Inhibrx trading halted, volatility trading pause
26d ago
INBX
Inhibrx trading resumes
PremiumThe Fly
Inhibrx trading resumes
26d ago
INBX
Inhibrx’s cancer drug drawing interest from Merck, Ono, Reuters says
PremiumThe Fly
Inhibrx’s cancer drug drawing interest from Merck, Ono, Reuters says
26d ago
MRK
INBX
Inhibrx up 39% at $117 after report of interest from Merck in cancer assets
PremiumThe Fly
Inhibrx up 39% at $117 after report of interest from Merck in cancer assets
26d ago
INBX
Inhibrx Biosciences Highlights Promising Ozekibart Colorectal Cancer Data
PremiumCompany Announcements
Inhibrx Biosciences Highlights Promising Ozekibart Colorectal Cancer Data
27d ago
8K
INBX
Inhibrx reports interim data from its Phase 1/2 study evaluating ozekibart
PremiumThe FlyInhibrx reports interim data from its Phase 1/2 study evaluating ozekibart
27d ago
INBX
Coinbase downgraded, Deere upgraded: Wall Street’s top analyst calls
Premium
The Fly
Coinbase downgraded, Deere upgraded: Wall Street’s top analyst calls
1M ago
DE
GD
Inhibrx initiated with a Buy at Stifel
Premium
The Fly
Inhibrx initiated with a Buy at Stifel
1M ago
INBX
Inhibrx reports Q4 EPS ($2.11) vs. ($3.09) last year
PremiumThe Fly
Inhibrx reports Q4 EPS ($2.11) vs. ($3.09) last year
2M ago
INBX
Inhibrx Biosciences Highlights 2026 Pipeline and Strategy
PremiumCompany Announcements
Inhibrx Biosciences Highlights 2026 Pipeline and Strategy
3M ago
8K
INBX
PremiumCompany Announcements
Inhibrx Biosciences Updates on Clinical Trials Progress
5M ago
8K
INBX
Inhibrx provides update on INBRX-106 Phase 2/3 clinical trial
PremiumThe Fly
Inhibrx provides update on INBRX-106 Phase 2/3 clinical trial
5M ago
INBX
PremiumCompany AnnouncementsInhibrx Biosciences Reports Promising Q3 2025 Results
6M ago
INBX
Inhibrx options imply 7.3% move in share price post-earnings
Premium
The Fly
Inhibrx options imply 7.3% move in share price post-earnings
6M ago
INBX
Premium
Pre-Earnings
Is INBX a Buy, Before Earnings?
6M ago
INBX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >